• Users Online: 94
  • Print this page
  • Email this page
Year : 2021  |  Volume : 18  |  Issue : 1  |  Page : 7-9

Denosumab in giant cell tumor of bone – science wins over evidence

Department of Orthopaedics, Amala Institute of Medical Sciences, Thrissur, Kerala, India

Correspondence Address:
Dominic Puthoor
Amala Institute of Medical Sciences, Thrissur, Kerala
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/joasis.joasis_11_21

Get Permissions

Denosumab is a relatively new drug and is used in the treatment of giant cell tumor (GCT) of bone. There are hardly any drugs such as denosumab, indication of which changed in a short period of 10 years. The author analyses the cause of this transformation of indication of that drug in the treatment of GCT of bone, based on the scientific ground, review of the literature, and personal experience.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded41    
    Comments [Add]    

Recommend this journal